Oxycontin

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxycontin (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone Hydrochloride, the active ingredient in Oxycontin, is an opioid analgesic presented as a strength/form for oral use. It is prescribed for management of moderate to severe pain in adult patients when alternative treatments are inadequate.

GNH India supplies Oxycontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mundipharma Ges.M.B.H

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxycodone Hydrochloride is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for:

Severe acute pain: provides rapid relief of intense pain following surgery or trauma.
Cancer‑related pain: helps control persistent pain associated with malignant disease.
Chronic non‑cancer pain: used when long‑term opioid therapy is deemed appropriate by a specialist.

How It Works

Oxycodone Hydrochloride binds primarily to μ‑opioid receptors in the brain and spinal cord, mimicking endogenous opioids. This activation reduces neuronal excitability and inhibits the transmission of nociceptive signals, resulting in decreased perception of pain.

Side Effects

Adverse reactions can vary in frequency and severity.

Common Side Effects

Constipation: reduced gastrointestinal motility.
Nausea: feeling of sickness, sometimes leading to vomiting.
Drowsiness: sedation or feeling unusually sleepy.
Dry mouth: reduced salivation.
Dizziness: light‑headed sensation, especially when standing.
Itching: mild skin irritation or pruritus.

Serious or Rare Side Effects

Respiratory depression: slowed or shallow breathing that can be life‑threatening.
Severe hypotension: marked drop in blood pressure.
Opioid use disorder: dependence or addiction.
Seizures: rare occurrence of convulsive episodes.
Anaphylaxis: acute allergic reaction with rash, swelling, and airway compromise.
adrenal insufficiency: rare hormonal imbalance affecting stress response.

Precautions & Warnings

When prescribing Oxycontin, clinicians should consider several safety measures:

Assess pain severity and treatment goals: ensure opioid therapy is appropriate.
Review patient history: check for prior opioid use, substance abuse, or respiratory conditions.
Monitor for signs of dependence: watch for cravings, tolerance, or withdrawal symptoms.
Avoid abrupt discontinuation: taper dose gradually to prevent withdrawal.
Educate patients on safe use: stress the importance of adhering to prescribed dosing and avoiding alcohol.
Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Oxycontin can interact with a range of other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

Benzodiazepines: combined use can cause profound respiratory depression.
CNS depressants: other sedatives increase risk of severe drowsiness and respiratory compromise.
MAO‑inhibitors: may precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely)

Antidepressants (SSRIs, SNRIs): may increase serotonin levels, raising serotonin syndrome risk.
Antihistamines: can enhance sedation and dizziness.
CYP3A4 inhibitors (e.g., ketoconazole): raise oxy‑contin plasma concentrations, requiring dose adjustment.

Frequently Asked Questions

Oxycontin is a brand‑name formulation of oxycodone hydrochloride that is used to treat moderate to severe pain when other analgesics are insufficient. It is commonly prescribed for acute postoperative pain, cancer‑related pain, and, in selected cases, chronic non‑cancer pain under specialist supervision.

Oxycodone hydrochloride works by binding to μ‑opioid receptors in the central nervous system. This receptor activation reduces the release of neurotransmitters that transmit pain signals, thereby lowering the perception of pain and providing analgesic relief.

The dose of Oxycontin is individualized by the prescribing clinician based on the patient’s pain intensity, prior opioid exposure, and overall health status. The prescriber determines the appropriate strength, dosing interval, and titration schedule.

Oxycontin is classified as a high‑risk medication in pregnancy and is generally avoided because it may cause fetal dependence, neonatal withdrawal, or birth defects. It is also excreted in breast milk, so breastfeeding mothers are advised to discuss safer alternatives with their healthcare provider.

To order Oxycontin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Oxycontin provides extended‑release oxycodone, offering longer‑lasting pain control compared with immediate‑release opioids such as morphine or hydromorphone. Its once‑daily dosing can improve adherence, but it also carries a higher risk of accumulation and respiratory depression if not titrated carefully.

Store Oxycontin at temperatures below 25 °C in its original container, protected from moisture, heat and direct sunlight. Do not expose the tablets to excessive humidity or extreme temperatures, as this may affect potency.

Oxycontin is taken orally, usually as a whole tablet swallowed with water. It should not be crushed, chewed, or broken, because altering the tablet can release the entire dose at once, increasing the risk of serious side effects.

The most serious risks include respiratory depression, severe hypotension, opioid dependence or addiction, and rare events such as anaphylaxis. Patients should be monitored closely for signs of breathing difficulty, extreme drowsiness, or allergic reactions, especially during dose adjustments.

Oxycontin is contraindicated in individuals with known hypersensitivity to oxycodone or any component of the formulation, those who have experienced severe respiratory depression, acute or severe asthma, or paralytic ileus. It should also be avoided in patients taking certain MAO‑inhibitors or who have a history of opioid misuse.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 10 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.